Snappy newsletters. Simple Facebook sharing. Spirited comments. Sweet features are waiting… GET THEM NOW!

Glaxo Buying Human Genome Sciences

After big drug failure in 2011, Human Genome failed to find higher bid

By Mark Russell, Newser Staff

Posted Jul 16, 2012 4:00 AM CDT

(Newser) – British pharma giant GlaxoSmithKline is poised to announce a $2.8 billion takeover of Human Genome Sciences, perhaps as early as today, reports Reuters. US-based Human Genome, which uses the human DNA sequence to develop drugs, balked at Glaxo's original $2.6 billion offer... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

There are no comments

Reuters (Source Grid »)

Health • Money

pharmaceutical companies • hostile takeover • GlaxoSmithKline • pharmaceutical industry • Human Genome Sciences

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: The Street

View Newser on the mobile website

Glaxo Buying Human Genome Sciences

After big drug failure in 2011, Human Genome failed to find higher bid

pharmaceutical companies • hostile takeover • GlaxoSmithKline • pharmaceutical industry • Human Genome Sciences

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?